Surgery without stitches

Dec 21, 2007

A thin polymer bio-film that seals surgical wounds could make sutures a relic of medical history. Measuring just 50 microns thick, the film is placed on a surgical wound and exposed to an infrared laser, which heats the film just enough to meld it and the tissue, thus perfectly sealing the wound.

Known as Surgilux, the device’s raw material is extracted from crab shells and has Food and Drug Administration approval in the US.

Early test results indicate that it has strongest potential for use in brain and nerve surgery because it can avoid the numerous disadvantages of invasive stictches/sutures, which fail to seal and can act as a source of infection.

Up to 11% of brain surgery patients have to return for repeat surgery due to leakage of cerebro-spinal fluid (CSF) and other complications arising from sutures.

Surgical sutures date back some 4,000 years, so a new approach is long overdue, according to one of the device’s inventors and leader of the Bio/polymer Research Group, UNSW scientist John Foster.

“Others have tried surgical glues but these are mainly gel-like so bonding to the tissue is uneven often resulting in leakages and they’re not easy to use. The strongest surgical glue is so toxic that it’s limited to external applications,” says Dr Foster. “Other devices use ultra-violet light to effect rather poor sealing, but UV rays are damaging to living cells

“The beauty of this is that infra-red laser doesn’t cause any tissue damage. Better still, Surgilux has anti-microbial properties, which deters post-operative infections.”

Foster and his team are working with micro-surgeon Marcus Stoodley who specialises in nerve repair. Based at the Prince of Wales Hospital Stoodley is excited about early test results.

“Surgilux is well suited to repairing damaged nerves because the gold standard -- sutures – inevitably cause damage to nerves and there is always some permanent loss of function.

“Our test results with rats have shown some degree of permanent nerve recovery within six weeks of operating.”

The researchers – who are looking for commercial backing to initiate clinical trials – are planning a second generation version of Surgilux that incorporates growth factors and perhaps stem cells to regenerate nerves.

Source: University of New South Wales

Explore further: New research demonstrates benefits of national and international device registries

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

NeilFarbstein
not rated yet Dec 21, 2007
Vulvox Nanobiotechnology Corporation has developed a breakthrough carbon nanotube adhesive that sticks to soft rubber and other materials with similar consistency especially human flesh and skin. It will be used to close woulds, reversibly and it clings to wet buccal tissue in the mouth and the tongue as well as wet flesh that is too wet with bodily fluids to apply adhesive bandages. You can view pictures of the nanotube adhesive at;

http://vulvox.tripod.com

navigate to the Nanotube adhesive press release link.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.